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S U M M A R Y
The ¢rst part of this reviewdiscussed the facilities that are needed to provide a competent diagnostic
virology service at the turn of the century. Just as important is to consider whowill run it. Hitherto, there
have been specialist virologists in most countries.Their roles have evolvedwith time, developing and
running avariety of diagnostic tests, often to answer local needs and their own curiosity, and frequently
linked to their research projects. Recently, the advent of an increasingly long list of commercial tests has
raised the real possibility of introducing standardized centrally validated testingmethods, and using them
to bring laboratories up to a similarly uniform level. Unfortunately, they have also had the e¡ect of seeming
tomake specialist virologists unnecessary, except in a fewcentral reference laboratories. As a consequence,
and because of increasing pressure on health service resources, vacated senior virology posts have remained
un¢lled and this now threatens the career structure of thosewhowant to become, and continue as,
virologists.This review explores these issues and o¡ers a possible solution.
ClinMicrobiol Infect 2000; 6: 342^347
W H A T I S T H E J O B T O B E D O N E ?
As I see it, the purely virologic components of the job descrip-
tion for a virologist are those listed inTable1. Others will put
them in a di¡erent orderöincluding putting no. 15 ¢rstöbut
most would include the same or similar items. The list does
not include those basic administrative activities, such as per-
sonnel management, maintenance of equipment and the fabric
of the building, managing accounts, and raising research
money, that are part of running any hospital or university
department in the new century. Nor does it include the neces-
sary overlaps in basic knowledge with clinical medicine,
pediatrics, immunology, blood transfusion, and other medical
disciplines, or with those aspects of bacteriology, parasitology
and mycology needed to work closely with specialist collea-
gues in these components ofmicrobiology.
Even with the involvement of commercial companies in
producing tests for viral diagnosis, the development and eva-
luation of new assays will remain an important component of
the virologist's job, because the companies will be understand-
ably reluctant to commit funds to developing new tests for
new viruses or diseases until the size of the diagnostic problem
has been assessed. Even though this reluctance may be less
apparent in those companies that allocate substantial money
to research and development, they, too, will not have access to
the essential patient material that is routinely available to a
front-line laboratory. Moreover, it is essential that new tests,
from whatever source, are properly and fully evaluated in a
clinical setting on clinical specimens. It is neither realistic nor
logical to expect commercial companies to be able to do this
on our behalf.
In addition, there is a need to retain a £exible capacity to
respond to new threats.With rapid travel to and from all parts
of the world, as well as the threat of global warming, viruses
and viral diseases are likely to spread, unpredictably, into areas
where they have not been found hitherto [1].There has to be a
capacity in front-line laboratories to recognize these new pro-
blems as they occur and to develop new tests to cope with
them.
The virologist has to do more than just supervise or do the
test; it is essential to interpret the results, negative or positive,
as well. Otherwise, it is equivalent to showing someone a
snapshot of a motorcar.The photo will show the make, a little
about its speci¢cation (equivalent to serotype) and, possibly,
its performance capabilities, but not, most importantly, its
direction and speed of travel. Doing a test for `viruses' tells one
no more than the single photo, but this limitation is not as
widely understood by clinicians as it needs to be. Sending a
single serum for `virus titers' is still a frequent occurrence.
Items 2, 3, 4, 6^9 and 11^14 (Table1) all require a depth of
virologic knowledge. It can be acquired by microbiologists, or
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anyone else with a grounding in science or medicine, if they
put in the necessary study- and work-time, but there is a limit
to the amount of information that any one individual can be
expected to learn and keep up to date. Their own disciplines
make large time demands as well, and it has become increas-
ingly di¤cult to be a polymath.`Fighting for resources' (item
15) will inevitably cause a con£ict of interest if attempted by
someone with a commitment to another discipline. Leaving
others to look after one's interests, and those of one's labora-
tory, is rarely satisfying.
At the heart of this question is whether virology includes
enough specialist information and skills to stand alone. Some
microbiologists continue to doubt that it does, claiming that it
is only a branch of their own discipline, with most tests now
becoming available as kits that can be operated routinely on
machines used in their own and other branches of laboratory
medicine. I disagree strongly with this view, although I am
convinced that the virology and microbiology services should
work very closely togetheröafter all, it is not always apparent
at ¢rst whether bacteria, viruses, fungi or parasites (or a com-
bination) are responsible for a patient's problem. Nevertheless,
the volume of work labeled either microbiology or virology is
such that no one person can adequately supervise both of
them. It can be, and indeed has been, argued that the person in
charge does not need to know all the ¢ne detail, but there are
obvious dangers in trying to interpret the results from tests
whose limitations, or even the principles on which they are
based, are not well understood.
In the UK, the Royal College of Pathologists has recog-
nized virology as a distinct discipline with its own separate
examination for Membership of the College (MRCPath, the
essential quali¢cation for running a laboratory in the UK).
However, this examination (and the corresponding one for
microbiologists) contains a mandatory section on the other
discipline. This attempt at half-melding the disciplines is,
unfortunately, not working wellöneither side regards the
other as being anything more than just marginally competent
in the alternative discipline. Thus, although this insight into
the other discipline helps essential cooperation, it does not
make microbiologists and virologists interchangeable. Never-
theless, blurring of this interface has sometimes led to the
appointment of a `microbiologist-with-an-interest-in-virol-
ogy' (MWAIIV), a hybrid which is attractive to hospital
administrators who perceive their virology needs to be con-
¢ned to kit-based tests: screening for HIV and hepatitis from
various causes, rubella susceptibility, limited viral serology
and some testing for `viral' antigens. They have therefore
decided that they do not require a comprehensive, proactive
virologic service including, for example, virus isolation or
more detailed monitoring of severe virus infections, while
failing to understand the need to interpret results from kit-
based tests just as thoroughly as any others.Their belief is that
an MWAIIV, either in charge or as second microbiologist, can
concentrate on the microbiology, while supervising the virol-
ogy part-time a`s necessary'. Nevertheless, such MWAIIV
appointments inevitably lower the standard and reduce the
scope of the virologic service to the localities where they are
made. All that can be said in favor of appointing an MWAIIV
(whose principal aim will usually be to climb the microbiol-
ogy career ladder) is that there are apparent similarities
between virology and microbiology, and some overlap
between them (including those tricky organisms like chlamy-
diae, rickettsiae and Clostridium di¤cile (with its toxin)), and it
will save avirologist salary.
WH O S H O U L D P RO VI D E T H E S ER V IC E ?
If Table1 de¢nes the virology service that must be available
somewhere within any country that intends to provide a com-
prehensive health service, then this service must be managed
competently by senior validated specialists who understand
the nature and activities of viruses. They must have devoted,
and continue to devote, enough time and e¡ort to understand
the breadth and depth of the topic and to keeping that knowl-
edge up to date. In a world that is demanding accredited stan-
Table 1 Virologic components of a virologist's job description
Components
1. Developing and supervising diagnostic tests, including those to
monitor new viral activities
2. Monitoring patients for evidence of new viruses locally, and
being aware of global viral activities
3. Understanding viral pathogenesis and pathology
4. Reporting and interpreting test results
5. Evaluating new commercial tests and systems
6. Monitoring and reporting viral epidemiology
7. Assessing the effectiveness of (new) viral vaccines
8. Advising on the use of antiviral drugs
9. Monitoring antiviral drug resistance and/or ineffectiveness
10. Liaising with microbiological and other laboratory medicine
colleagues
11. Liaising with clinicians by telephone and in person
12. Keeping up with current literature on viruses and their
activities, and other relevant literature
13. Attending clinical virology and other relevant meetings,
including administrative ones
14. Teaching and training
(a) Technical staff
(b) Medical, dental and other students
(c) Colleagues, both medical and scienti®c
15. Fighting for resources
16. Applying for, and administering, research grants
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dards, their training and quali¢cations must be agreed and
approved.To be e¡ective, this trainingmust includemore than
just a token minor virology component as part of a broader
competence in general pathology. In many other European
countries, an appropriate quali¢cation must be acquired, in
part through spending a de¢ned time, measured in years,
learning the job.
Table 2 outlines, very brie£y, these training requirements
in 17 European countries, and shows that there is considerable
variation inwhat is required, both in terms of the time spent in
training and the examinations which have to be passed before
the trainee is quali¢ed to take charge of a diagnostic virology
laboratory. Nevertheless, the vast majority require evidence of
training and competence. Table 2 also indicates the extent to
which virology is recognized as a separate discipline, while
re£ecting the number of specialist virology laboratories in
each country.Where there are only a small number of these
laboratories, there is not the same need for the detailed regula-
tions necessary to guide larger numbers of trainees.
However, before deciding on what kind of specialist to
appoint, it is important to decide the level of service appropri-
ate to themedical care undertaken locallyor within the region.
Here, it is helpful to consider three possible levels of virology
service (Table 3). A level A laboratory provides a full and com-
prehensive service which can undertake investigations of any
virologic phenomena using a wide variety of tests, either
directly in the laboratory itself or through national or interna-
tional contacts for highly specialized items. It will also provide
most of the reference functions for levels B and C. A level A
laboratory must be sta¡ed by quali¢ed specialist virologists,
part of whose role is training others. To function well, a level
A laboratory must have same-site contact with a broad spec-
trumof both patients and clinicians. Amedically quali¢ed vir-
ologist must be available at all times to provide advice on tests,
collecting specimens, results and treatment. Sometimes this
must be done in person at the bedside.
A level B laboratory is necessary in the increasing number
of hospitals that look after immunocompromised patients:
transplants, patients with AIDS, those with malignant diseases
on immunosuppressive regimens, and those with immunode-
¢ciencies. Because their management is long-term and will
require a wide range of virologic techniques, including some
which are normally part of reference facilities, the level of vir-
ologic expertise necessary will be only a little below that of
level Aöperhaps lacking only the capacity to identify some
exotic imported virusesöbut undertaking some reference
functions, often through personal interests and experience.
A level C laboratory is more basic, andwill o¡er amore lim-
ited service: serologic screening (often using commercial kits
and assay systems) for women in pregnancy, monitoring for
infections by HIV and hepatitis (A^C, and others as kits
become available) in patients and sta¡, and doing simple tests Ta
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with standardized reagents and kits for antigen detection.
Except for possible personal interests, the basic level C service
will depend on the other levels for the evaluated tools needed
for its work. It will not be expected to develop new tests and,
in particular, will not provide the expensive and skilled cell
culture for virus isolation and growth that, in addition to giv-
ing a virus diagnosis, provides material onwhich to base more
new tests and techniques.
Only a few level A laboratories will be needed in any indivi-
dual country. Historically, they have often existed as separate
institutes, in the UK and elsewhere, but this has rarely been
completely successful in the absence of immediate and daily
clinical contact, and amajor teaching hospital provides the best
infrastructure for such a laboratory. Level B laboratories are
more common, especially as more and more hospitals expand
into transplant surgery (including bone marrow transplants)
and/or into managing such patients long-term. There is no
clearlyde¢ned border between the level of workdone in A and
B laboratories, and the sitingof some levelA reference testswill
depend on local needs and the interests of individuals. Listing
themseparately is usefulmostly forde¢ning the twoconcepts.
In reality, the distinction between levels B and C may not
be clear-cut, and will also vary with time. However, both
levels A and B must be adequately sta¡ed with certi¢ed and
experienced virologists, who can train both new virologic
recruits and MWAIIVs in the virology they need. In contrast,
some level C laboratories might be run by an MWAIIV, but a
specialist virologist must be appointed if the laboratory has a
large virology workload. The level of virologic knowledge
required to manage the service e¡ectively, rather than the
scope of tests done, will set the cut-o¡ point between them.
Given average drive and initiative, a virologist in a level C
laboratory will want to develop it to level B, and should be
encouraged to do so.
There can, and will be, arguments over which laboratories
should adopt which service levels, but some virologists are
needed in every country, and in each regionwhere the country
itself is large. and they must have a realistic career structure.
No one of intelligence and ambition will start a career that
o¡ers only a small chance of reaching a satisfactory (e.g. con-
sultant, or equivalent, largely autonomous) position in his/her
health service. Consequently, there must be enough level A
and B laboratories with established posts (and unequivocally
Table 3 Levels of virologic service which can be provided
Level Outline of service provideda
A Full armamentarium of tests, including virus isolation, virus identi®cation, molecular techniques and substantial reference functions
Able to evaluate all new and modi®ed diagnostic kits
Advice, in person or if unavoidable on the phone, on all aspects of virus diseases, their management and their treatment
Laboratory run and staffed by fully trained specialist virologists with specialist advice and testing available at all times
Provides specialist training for relevant quali®cations
Laboratory probably called: (Regional/National) Virus Laboratory
B More restricted service, relating to local needs (e.g. transplant surgery, management of AIDS)
Includes rapid detection of virus and viral components, some viral isolation and viral identi®cation
Some molecular techniques and occasional reference functions, re¯ecting local research and interests
Able to evaluate some new or modi®ed kits, depending on breadth of experience
General advice, in person at bedside, from a specialist virologist on prevalent virus problems, including the taking and transport
of specimens
Service run by fully trained specialist virologist but specialist advice may not be available at all times, particularly out of hours
Some virology testing available out of hours
Based in a specialist, i.e. training, laboratory able to train in all routine, but not all reference, functions
Laboratory probably called: Virus Laboratory
C Basic virology service only, based almost exclusively on kits evaluated elsewhere, and mostly used for detecting antibodies and
antigens in serum
Some use of kits for rapid identi®cation of virus in patient material
No virus isolation or other advanced (molecular) techniques
Some out-of-hours testing by on-call technical staff, not necessarily widely experienced in virologic techniques
No local virology specialist available routinely and service may be run by a general microbiologist or
microbiologist-with-an-interest
Laboratory probably called: Virology Section
aGeneralizations only, to give the `¯avor' of the service provided. Individual laboratories may not ®t cleanly into a particular level.
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designated as such) to provide this career structure as well as
meeting service needs. Otherwise, would-be recruits will
decide that their prospects are much better as orthodox micro-
biologists, or even as MWAIIVs, and virology will conse-
quently wither as a specialty. If no positive action is taken to
prevent it, this will proceed inexorably.
T H E C H A L LE N G E
As health services have grown in complexity and the overall
budget ¢gures have increased, there has been a tendency to
delegate decision-making (in the UK, at least) to local levels.
Although the numbers recommended for each specialty may
be decided centrally at ministry level, these recommendations
do not carry funds with them, and, when local priorities favor
the major disciplines (often for well-argued reasons), the min-
ority specialties feel the squeeze. I believe that virology is
beginning to lose out in this competitive environment.
The two beliefsöthat virology can be done by a microbiol-
ogist with a kit, and that there is, or soon will be, a kit for
everythingöare, I believe, dangerously complacent. It can't,
and there won't be. (Even where adequate kits have been
developed, they will inevitably be well behind the sharp edge
of new knowledge.) I do not think that virology faces active
discrimination, but it is being harmed by this sort of woolly
thinking and also from a widely held belief that virology is a
national, and not a local, need.These mistaken ideas are being
reinforced because one of the justi¢cations for providing r`ou-
tine' virologic diagnosis of non-life-threatening infections is,
indeed, to provide national epidemiologic data.There is a very
important national requirementöbut the overlap between
national and local need is subtle and complex; the former can-
not bemet without the latter.
Let me repeat that statement so that there can be no misun-
derstanding.There will be noworthwhile national data unless
they are underpinned by a competent and valued local service.
It must be clearly understood that it is impossible to run
national surveillance without basing it on a local diagnostic
service providing quick results helpful to the local clinicians in
their decision-making, making them aware that the service
exists, and constantly encouraging them to use it through
sending the essential specimens. InTable1, item 6 (monitoring
and reporting viral epidemiology) was not given particular
emphasis, but the collection of such data is a very important
function for any virologic laboratory.Without this informa-
tion, the overall picture of which viruses are prevalent, and
roughly how frequently (andwhich are therefore possible can-
didates for prevention by immunization), will not be appar-
ent. It is worth remembering that the former Soviet Union
claimed for some time to be AIDS-freeöuntil they started
testing. The easiest way to eliminate a disease is to decline to
look for evidence of its presence. However, local fund-holders
are understandably reluctant to underwrite what they see as
national activities.
If, as seems to be the case, the virology service is threatened
because local priorities lie elsewhere even though it retains a
signi¢cant national justi¢cation, then it seems logical to ¢nd a
way to underwrite the service nationally.There are precedents
for such safeguardsöother small, threatened specialties, such
as pediatric pathology, have been de¢ned and defended
nationally in the UKöbut, at the moment, virology and vir-
ologists are not seen to be similarly endangered species. None-
theless, the threat is there, even if unexpressed in Health
Service documents, and many virologists feel it strongly.
There are few published references to con¢rm this concern,
but the lengthening list of un¢lled posts, many of them
never advertised, testi¢es to the crisis. I believe that there is
an urgent need to assess and designate virology posts at all
levels, with protected central funding to ensure that they are
kept ¢lled.
Coming from the UK, this plea for national-level support
may seem strange, given the presence of the Public Health
Laboratory Service (PHLS), but here lies a paradox.The PHLS
has indeed the necessary mandate, but has always declined to
designate more than a few posts as `Consultant Virologist'
ones, in the interests of £exibility and retaining the option of
appointing a `Consultant Microbiologist' (with an implied,
but not stated,`interest') if no suitable virologist applies when
the post becomes vacant. This can easily result in an overall
loss of designated virology posts, thereby unintentionally
making the situationworse and helping to ensure that the sup-
plyof virologists gradually dries up.
In these reviews, I have been considering only the senior
graduate (medical and scienti¢c) posts. Just as important are
themembers of the technical sta¡ who do the day-to-day test-
ing.With the advent of versatile machines running standar-
dized tests with kits for the numerically large screening load,
another crisis is looming. Loading sera into trays, and trays
into machines, does not demand high levels of technical train-
ing, but understanding the results and recognizing the non-
sense ones does. A gap is now starting to develop in the
technical hierarchyöthe need for juniors is waning (`they can
be replaced with laboratory assistants'), but the higher grades
are, and will continue to be, needed.This means that a serious
shortage of trained replacements for today's seniors will
develop andmust also be addressed.
C O N C L U S IO N S
Wedo, and alwayswill, need specialist virologistsöto provide
the more specialized aspects of virologic diagnosis, to train
âãå Clinical Microbiology and Infection, Volume 6 Number 7, July 2000
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medical, dental and veterinary students and their own succes-
sors, tomonitor the community for new viruses and new viral
activities, and generally to keep an eye on what is infecting
members of our various communities. Medically quali¢ed
virologists with hands-on experience of clinical and diagnos-
tic virology should teach medical and other studentsöthe
necessary subtlety of understanding cannot be learnt from a
book. The argument that a`nyone can teach students, they
don't need to know anything in depth' is entirely spurious. I
still believe strongly in the old Scottish tradition that the pro-
fesso, r should teach the ordinary class, i.e. that the teacher with
the most experience of all aspects of that subject, whatever it
may be, should put the ¢rst ideas into freshminds.
There must be clinical virologists in a health service to
bridge the yawning gap between science-based research virol-
ogists and cliniciansöa role that microbiologists cannot ¢ll.
The career pyramid for these virologists must be big enough
for long-termviability, with a broad enough base to allow for
some wastage, and we must not allow our clinical virologists
towither away through sheer inattention, especially when this
re£ects basic misconceptions.
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